AI Science Tracker

The University of Texas at Austin

2 discoveries from 2021 to 2026

Discoveries

Machine learning and directed evolution improved an L-Dopa-producing monooxygenase

Zero-shot protein models prioritized HpaBC substitutions, which were experimentally assayed with a L-Dopa-responsive GFP biosensor. EVOLVEpro then combined experimentally validated substitutions, including directed-evolution-derived variants, and selected higher-order designs. The best reported combined variants produced up to 57–58 times the wild-type fluorescence signal under the stated assay conditions. This is a biosensor proxy for L-Dopa production, not a purified-enzyme kinetic measurement; the work also builds on prior directed-evolution mutations and does not establish clinical benefit.

Technology: MutCompute, ProteinMPNN, ESM protein language models and EVOLVEpro combinatorial design

Family ESM / ESMFold: profile · models page

Publication: Preprint · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Preprint
  • Test type: direct test
  • Tested: 329 model-predicted variants were assayed; 19 showed at least 1.25-fold biosensor signal. EVOLVEpro-selected combined variants yielded up to 57–58-fold normalized fluorescence relative to wild type under the reported assay conditions.
  • Still unknown: Fluorescence from a DopA/GFP biosensor is an indirect L-Dopa-production proxy, not a purified-enzyme catalytic constant. The work includes directed-evolution-derived mutations; G295T had prior directed-evolution support. No human therapeutic efficacy is established.
  • AI role: MutCompute, ProteinMPNN and ESM prioritized single substitutions for experimental testing; EVOLVEpro combined tested mutations and iteratively selected higher-order variants, including designs incorporating directed-evolution results.

Evidence sources: https://api.biorxiv.org/details/biorxiv/10.64898/2026.07.31.742090 · https://www.biorxiv.org/content/10.64898/2026.07.31.742090v1.full

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 17 Nov 2026. Review scope: Primary bioRxiv v1 API metadata and Crossref posted-date metadata checked; primary v1 full-text indexed extract reviewed for methods, biosensor-normalized outcomes, model role and affiliation. Direct full-text page open was blocked..

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

MutCompute guides thermostable Bst DNA polymerase variants

MutCompute predicted substitutions in Bst DNA polymerase; the authors constructed and tested variants in loop-mediated isothermal amplification assays. The Mut235 triple variant showed the highest activity among four tested triple-mutant variants and remained active at 73 °C; its reported melting temperature was 78.1 °C. The evidence is in vitro and does not establish clinical diagnostic performance. The journal article cites a bioRxiv v1 posted 2021-04-15, but that version’s full text was inaccessible in this review; this entry uses the verified journal result and does not claim when the Mut235 result first appeared.

Technology: MutCompute machine-learning amino-acid environment scoring

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: The authors assayed ML-predicted Bst polymerase substitutions in LAMP/LAMP-OSD reactions. Mut235 showed the highest activity among four triple-mutant variants tested, supported amplification at 73 °C, and had a measured melting temperature of 78.1 °C versus 75.5 °C for parental Bst-LF in the reported thermal-shift assay.
  • Still unknown: The article cites an earlier bioRxiv preprint dated 2021-04-15, but this check did not retrieve its full v1 text; no claim is made that every final-version assay/result was present in v1. Results are in-vitro amplification assays, not clinical diagnostic validation.
  • AI role: MutCompute machine learning predicted amino-acid substitutions in Bst DNA polymerase; the authors constructed and assayed variants including Mut235.

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC9514386/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 17 Nov 2026. Review scope: Primary PMC full journal text for MutCompute, LAMP assays, University of Texas affiliation and measured variants; primary bioRxiv v1 endpoint was attempted but blocked, so earlier-version result details remain bounded to what the journal and cited metadata support..

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open the interactive profile for the timeline, or browse all organizations and model families.